This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

West Breaks Ground On New Manufacturing Facility In India

“This investment is important to our strategy of partnering with customers in India and the Asia Pacific region to help them provide medicines to patients more efficiently, reliably and safely,” said Warwick Bedwell, President, Pharmaceutical Packaging Systems, Asia Pacific Region. “When the facility is completed, we anticipate a reduction in lead times for supply to our customers in India. By leveraging our global sourcing activities and process engineering expertise, we will be able to carefully manage the overall costs of production.”

West plans to file Drug Master Files for the plant with the United States Food and Drug Administration and Heath Canada’s Bureau of Pharmaceutical Sciences.

About West

West’s innovative systems, medical device and pharmaceutical component solutions are designed to improve the safety and administration of injectable drugs. West’s proprietary materials science, formulation research and manufacturing technologies can advance the quality, therapeutic value, development speed and rapid market availability of pharmaceuticals, biologics and vaccines. Sales in 2011 totaled US$1.2 billion. West supports its customers from sales, manufacturing, customer support and research and development from locations in North and South America, Europe, Asia, India and Australia. Global headquarters are in Lionville, Pa., USA. Visit West online at www.westpharma.com. Follow West at www.twitter.com/WestPharma.

Copyright Business Wire 2010
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,965.84 -104.56 -0.58%
S&P 500 2,094.45 -20.04 -0.95%
NASDAQ 4,945.1510 -71.7780 -1.43%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs